ROS leads to MnSOD upregulation through ERK2 translocation and p53 activation in selenite-induced apoptosis of NB4 cells

FEBS Letters

Volumn 584, Issue 11, 2010, Pages 2291-2297

  Li, Zhushi ^a   Shi, Kejian ^a   Guan, Liying ^a   Cao, Tingming ^a   Jiang, Qian ^a   Yang, Yang ^a   Xu, Caimin ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

Extracellular regulated kinase; Manganese superoxide dismutase; Nuclear translocation; P53; Reactive oxygen species

Indexed keywords

MANGANESE SUPEROXIDE DISMUTASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN MDM2; PROTEIN P53; REACTIVE OXYGEN METABOLITE; SODIUM SELENITE; SUPEROXIDE;

APOPTOSIS; ARTICLE; CELL LINE; CELL NUCLEUS; CELL STRAIN NB4; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INDUCTION; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

APOPTOSIS; CELL LINE, TUMOR; GENES, P53; HUMANS; PROTEIN TRANSPORT; REACTIVE OXYGEN SPECIES; SODIUM SELENITE; SUPEROXIDE DISMUTASE; SUPEROXIDES; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 77952951645     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2010.03.040     Document Type: Article

References (46)

1. Sanmartín C., Plano D., Palop J.A. Selenium compounds and apoptotic modulation: a new perspective in cancer therapy. Mini Rev. Med. Chem. 2008, 8:1020-1031.
2. Sinha R., El-Bayoumy K. Apoptosis is a critical cellular event in cancer chemoprevention and chemotherapy by selenium compounds. Curr. Cancer Drug Targets 2004, 4:13-28.
3. Asfour I.A., El Shazly S., Fayek M.H., Hegab H.M., Raouf S., Moussa M.A. Effect of high-dose sodium selenite therapy on polymorphonuclear leukocyte apoptosis in non-Hodgkin's lymphoma patients. Biol. Trace Elem. Res. 2006, 110:19-32.
4. Guan L., Han B., Li Z., Hua F., Huang F., Wei W., Yang Y., Xu C. Sodium selenite induces apoptosis by ROS-mediated endoplasmic reticulum stress and mitochondrial dysfunction in human acute promyelocytic leukemia NB4 cells. Apoptosis 2009, 14:218-225.
5. Dong H., Ying T., Li T., Cao T., Wang J., Yuan J., Feng E., Han B., Hua F., Yang Y., Yuan J., Wang H., Xu C. Comparative proteomic analysis of apoptosis induced by sodium selenite in human acute promyelocytic leukemia NB4 cells. J. Cell. Biochem. 2006, 98:1495-1506.
6. Guan L., Han B., Li J., Li Z., Huang F., Yang Y., Xu C. Exposure of human leukemia NB4 cells to increasing concentrations of selenite switches the signaling from pro-survival to pro-apoptos. Ann. Hematol. 2009, 88:733-742.
7. Han B., Wei W., Hua F., Cao T., Dong H., Yang T., Yang Y., Pan H., Xu C. Requirement for ERK activity in sodium selenite-induced apoptosis of acute promyelocytic leukemia-derived NB4 cells. J. Biochem. Mol. Biol. 2007, 40:196-204.
8. Cao T., Hua F., Xu C., Han B., Dong H., Zuo L., Wang X., Yang Y., Pan H., Zhang Z. Distinct effects of different concentrations of sodium selenite on apoptosis, cell cycle, and gene expression profile in acute promyeloytic leukemia-derived NB4 cells. Ann. Hematol. 2006, 85:434-442.
9. Zuo L., Li J., Yang Y., Wang X., Shen T., Xu C., Zhang Z. Sodium selenite induces apoptosis in acute promyelocytic leukemia-derived NB4 cells by a caspase-3-dependent mechanism and a redox pathway different from that of arsenic trioxide. Ann. Hematol. 2004, 83:751-758.
10. Culotta V.C., Yang M., O'Halloran T.V. Activation of superoxide dismutases: putting the metal to the pedal. Biochim. Biophys. 2006, 763:747-758.
11. Giovambattista P., Renata C., Barbara B., Salvatore F., Daniela F., Silvia B., Tommaso G. Mitochondrial superoxide dismutase: a promising target for new anticancer therapies. Curr. Med. Chem. 2004, 11:1299-1308.
12. Ramos J.W. The regulation of extracellular signal-regulated kinase (ERK) in mammalian cells. Int. J. Biochem. Cell Biol. 2008, 283:9248-9256.
13. Baccarini M. Second nature: biological functions of the Raf-1 " kinase" FEBS Lett. 2005, 579:3271-3277.
14. Ma C., Bower K.A., Chen G., Shi X., Ke Z.J., Luo J. Interaction between ERK and GSK3beta mediates basic fibroblast growth factor-induced apoptosis in SK-N-MC neuroblastoma cells. J. Biol. Chem. 2008, 283:9248-9256.
15. Brunet A., Roux D., Lenormand P., Dowd S., Keyse S., Pouysségur J. Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry. EMBO J. 1999, 18:664-674.
16. Ranganathan A., Yazicioglu M.N., Cobb M.H. The nuclear localization of ERK2 occurs by mechanisms both independent of and dependent on energy. J. Biol. Chem. 2006, 281:15645-15652.
17. Yazicioglu M.N., Goad D.L., Ranganathan A., Whitehurst A.W., Goldsmith E.J., Cobb M.H. Mutations in ERK2 binding sites affect nuclear entry. J. Biol. Chem. 2007, 282:28759-28767.
18. Fridman J.S., Lowe S.W. Control of apoptosis by p53. Oncogene 2003, 22:9030-9040.
19. O'Connor J.C., Wallace D.M., O'Brien C.J., Cotter T.G. A novel antioxidant function for the tumor-suppressor gene p53 in the retinal ganglion cell. Invest. Ophthalmol. Vis. Sci. 2008, 49:4237-4244.
20. Hussain S.P., Amstad P., He P., Robles A., Lupold S., Kaneko I., Ichimiya M., Sengupta S., Mechanic L., Okamura S., Hofseth L.J., Moake M., Nagashima M., Forrester K.S., Harris C.C. P53-induced up-regulation of MnSOD and GPx but not catalase increases oxidative stress and apoptosis. Cancer Res. 2004, 64:2350-2356.
21. Pivoriūnas A., Savickiene J., Treigyte G., Tunaitis V., Navakauskiene R., Magnusson K.E. PI 3-K signaling pathway suppresses PMA-induced expression of p21WAF1/Cip1 in human leukemia cells. Mol. Cell. Biochem. 2007, 302:9-18.
22. Ito K., Nakazato T., Yamato K., Miyakawa Y., Yamada T., Hozumi N., Segawa K., Ikeda Y., Kizaki M. Induction of apoptosis in leukemic cells by homovanillic acid derivative, capsaicin, through oxidative stress: implication of phosphorylation of p53 at Ser-15 residue by reactive oxygen species. Cancer Res. 2004, 64:1071-1078.
23. Ito K., Nakazato T., Miyakawa Y., Yamato K., Ikeda Y., Kizaki M. Caffeine induces G2/M arrest and apoptosis via a novel p53-dependent pathway in NB4 promyelocytic leukemia cells. J. Cell. Physiol. 2003, 196:276-283.
24. Mata-Greenwood E., Cuendet M., Sher D., Gustin D., Stock W., Pezzuto J.M. Brusatol-mediated induction of leukemic cell differentiation and G(1) arrest is associated with down-regulation of c-myc. Leukemia 2002, 16:2275-2284.
25. García-Cazarín M.L., Smith J.L., Clair D.K., Piascik M.T. The alpha1D-adrenergic receptor induces vascular smooth muscle apoptosis via a p53-dependent mechanism. Mol. Pharmacol. 2008, 74:1000-1007.
26. Dias S.S., Hogan C., Ochocka A.M., Meek D.W. Polo-like kinase-1 phosphorylates MDM2 at Ser260 and stimulates MDM2-mediated p53 turnover. FEBS Lett. 2009, 583(22):3543-3548.
27. Tibbetts R.S., Brumbaugh K.M., Williams J.M., Sarkaria J.N., Cliby W.A., Shieh S.Y., Taya Y., Prives C., Abraham R.T. A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev. 1999, 15:152-157.
28. Siliciano J.D., Canman C.E., Taya Y., Sakaguchi K., Appella E., Kastan M.B. DNA damage induces phosphorylation of the amino terminus of p53. Genes Dev. 1997, 11:3471-3481.
29. Jaiswal A.S., Narayan S. SN2 DNA-alkylating agent-induced phosphorylation of p53 and activation of p21 gene expression. Mutat. Res. 2002, 500:17-30.
30. Wolf D., Rotter V. Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells. Proc. Natl. Acad. Sci. USA 1985, 82:790-794.
31. Banerjee D., Lenz H.J., Schnieders B., Manno D.J., Ju J.F., Spears C.P., Hochhauser D., Danenberg K., Danenberg P., Bertino J.R. Transfection of wild-type but not mutant p53 induces early monocytic differentiation in HL60 cells and increases their sensitivity to stress. Cell Growth Differ. 1995, 6:1405-1413.
32. Soddu S., Blandino G., Citro G., Scardigli R., Piaggio G., Ferber A., Calabretta B., Sacchi A. Wild-type p53 gene expression induces granulocytic differentiation of HL-60 cells. Blood 1994, 83:2230-2237.
33. Sugimoto K., Toyoshima H., Sakai R., Miyagawa K., Hagiwara K., Ishikawa F., Takaku F., Yazaki Y., Hirai H. Frequent mutations in the p53 gene in human myeloid leukemia cell lines. Blood 1992, 79:2378-2383.
34. Kastan M.B., Radin A.I., Kuerbitz S.J., Onyekwere O., Wolkow C.A., Civin C.I., Stone K.D., Woo T., Ravindranath Y., Craig R.W. Levels of p53 protein increase with maturation in human hematopoietic cells. Cancer Res. 1991, 51:4279-4286.
35. Husbeck B., Nonn L., Peehl D.M., Knox S.J. Tumor-selective killing by selenite in patient-matched pairs of normal and malignant prostate cells. Prostate 2006, 66:218-225.
36. Nilsonne G., Sun X., Nystrom C., Rundlof A.K., Potamitou Fernandes A., Bjornstedt M., Dobra K. Selenite induces apoptosis in sarcomatoid malignant mesothelioma cells through oxidative stress. Free Radic. Biol. Med. 2006, 41:874-885.
37. Huang F., Nie C., Yang Y., Yue W., Ren Y., Shang Y., Wang X., Jin H., Xu C., Chen Q. Selenite induces redox-dependent Bax activation and apoptosis in colorectal cancer cells. Free Radic. Biol. Med. 2009, 46:1186-1196.
38. Strassburger M., Bloch W., Sulyok S., Schüller J., Keist A.F., Schmidt A., Wenk J., Peters T., Wlaschek M., Lenart J., Krieg T., Hafner M., Kümin A., Werner S., Müller W., Scharffetter-Kochanek K. Heterozygous deficiency of manganese superoxide dismutase results in severe lipid peroxidation and spontaneous apoptosis in murine myocardium in vivo. Free Radic. Biol. Med. 2005, 38:1458-1470.
39. Kirby K., Hu J., Hilliker A.J., Phillips J.P. RNA interference-mediated silencing of Sod2 in Drosophila leads to early adult-onset mortality and elevated endogenous oxidative stress. Proc. Natl. Acad. Sci. USA 2002, 99:16162-16167.
40. Epperly M.W., Sikora C.A., DeFilippi S.J., Gretton J.A., Zhan Q., Kufe D.W. Manganese superoxide dismutase (SOD2) inhibits radiation-induced apoptosis by stabilization of the mitochondrial membrane. Radiat. Res. 2002, 157:568-577.
41. Liu Y., Borchert G.L., Donald S.P., Surazynski A., Hu C.A., Weydert J., Oberley L.W., Phang J.M. MnSOD inhibits proline oxidase-induced apoptosis in colorectal cancer cells. Carcinogenesis 2005, 28:1335-1342.
42. Fisher C.J., Goswami P.C. Mitochondria-targeted antioxidant enzyme activity regulates radioresistance in human pancreatic cancer cells. Cancer Biol. Ther. 2008, 7:1271-1279.
43. Kanwar M., Chan P.S., Kern T.S., Kowluru R.A. Oxidative damage in the retinal mitochondria of diabetic mice. possible protection by superoxide dismutase. Invest. Ophthalmol. Vis. Sci. 2007, 48:3805-3811.
44. Mihara M., Erster S., Zaika A., Petrenko O., Chittenden T., Pancoska P., Moll U.M. P53 has a direct apoptogenic role at the mitochondria. Mol. Cell 2003, 11:577-590.
45. Endo H., Kamada H., Nito C., Nishi T., Chan P.H. Mitochondrial translocation of p53 mediates release of cytochrome c and hippocampal CA1 neuronal death after transient global cerebral ischemia in rats. J. Neurosci. 2006, 26:7974-7983.
46. Komarov R.G., Komarova E.A., Kondratov R.V., Christov-Tselkov K., Coon J.S., Chernov M.V., Gudkov A.V. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 1999, 285:1733-1737.